about
Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma.Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.Treatment of congenital liver cysts. A surgical technique tailored through a 35-year experience.Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.Indications, technique, and results of robotic pancreatoduodenectomy.The learning curve in robotic distal pancreatectomy.[Significance of biliary lithiasic pathology in the etiopathogenesis of carcinoma of the large intestine]Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue.Low value of detection of KRAS2 mutations in circulating DNA to differentiate chronic pancreatitis to pancreatic cancer.A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression.Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate: a single-institution experience.An expression signature of phenotypic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis.Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.Case-report: Metastases in a low-stage middle-graded HCC in cleared HCV infection, non-cirrhotic liver: Surgical therapy.[Rectal cancer in women][Physiopathological changes after interventions for rectal cancer][Therapy of massive anastomotic hemorrhage after anterior mechanical rectocolonic resection]Rectal cancer: new trends in pre- and intraoperative stagingTissue CEA as prognostic indicator in a series of 31 cases of gastric cancer[Experimental studies on the pathogenesis of acute hemorrhagic pancreatitis: proposal of an original study model]Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpressionRecurrent intussusception of the sigmoid colon caused by a transanal protruding sessile tubulo-villous malignant polypClinical behavior of solitary fibrous tumors of the pleura. An immunohistochemical study[A case of carcinoid with multiple sites in the jejunum and distal ileum][Transpyloric prolapse of a gastric carcinoma arising from a pedunculated hyperplastic polyp]Type B1 thymoma in multiple endocrine neoplasia type 1 (MEN-1) syndromeTotal lateral sphincterotomy for anal fissureLymph node dissection in papillary or follicular thyroid carcinomaTreatment of giant intramuscular hemangioma: a multistep approach in three patients[Primary adenocarcinoma of the ureter. Case report]Endoscopic retrograde cholangiography for intrabiliary rupture of hydatid cystSurgical treatment of pancreatic head carcinoma in elderly patientsSurgical treatment of liver metastases from colorectal cancer in elderly patientsSequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experienceUnexpected Prolonged Survival After Extended and Emergent Resection of Pancreatic Metastases from Renal Cell CarcinomaSurgical-only treatment of pancreatic and extra-pancreatic metastases from renal cell carcinoma - quality of life and survival analysis
P50
Q33783730-F553181D-B7F9-40E3-9596-7776E11BA791Q34672477-9A5F3ABC-954B-45C7-8397-E4CE6F80C386Q37322983-E57EF027-F895-404F-B52C-621AECA69E8DQ37476446-1B78CA83-32FC-438E-92EE-F97CF379B6AAQ37580201-5BB9EF59-688C-42AC-9344-070B51774E7DQ39231420-8573CBBF-D2E7-4F3E-9F54-82215E290C60Q39561085-FA94E42D-D72B-444A-9115-5E5E7C31984CQ40586897-6FF050CE-647B-4CA5-A6B9-499A8AB59B03Q40922656-1A18DD2B-3F6B-43FC-8DC1-2AC5EEDB8A7EQ41591916-5A12AD90-5111-4A5A-B4AE-C42D0BF17F60Q42222888-0A72AAD3-F9D3-447F-8F14-E0592CB9B95AQ43248706-25310AD3-A591-4D55-AD11-5D2BBDDF5000Q46519493-99D240BF-740F-4963-90CC-1ECD3D48BAB6Q53186782-060809FC-23ED-4176-A2E8-B1219189C742Q53737270-1828B2A2-6E1C-420D-AECE-59BF2DEFEF45Q54318224-892DA133-6E24-471C-A51B-B186B35DC845Q54612624-9B4FB848-BA7A-4069-BAE4-A52B4EEC2721Q55282213-12E7E933-2ED9-4F87-9A12-C00F710C20C4Q57648750-49EEE6DB-A0B5-404B-8BFC-DF8CE998972BQ67942880-B15540E4-6FAD-4BFC-9EF8-C98BBC33F330Q67945650-37CA6B24-439A-4A31-91E2-A95EB4365BADQ68039371-77CF8CF1-886A-41C8-B6C6-1FE92CF2C61FQ70249673-6F6AD7DE-4DBE-4285-BF41-C0C6B23EC20EQ71485402-8B353E4D-9B97-44AD-B7FD-753861353CADQ73043522-6F62DA4E-A490-49E4-BB01-D6D0BF5D798EQ73505306-CF156BAF-39D5-468A-9E03-D78E9D079975Q73505309-1AE9A7C3-530C-4FCC-9D8D-972A42D72787Q73792182-FEA5572D-4D23-4E51-96E0-61660E559BD6Q74499433-4B79D112-83D8-46B1-90E7-CD4E1B1EF48DQ77120668-7473A1D7-3593-44BB-81B9-3B21EDD3166EQ78760942-B873AE7C-A389-43FE-A8C4-7C43AB844010Q80493727-9182DC33-B6D4-450B-A9F2-524613268D00Q81005630-ECFF7C28-8A02-427A-9B9E-EFAC03FA788DQ81049193-AA4311C6-0407-43EB-A8F8-CD9515EEDC2DQ82407539-9E766271-E163-4667-A9FB-4FB0FEB9D576Q82615807-C1D8EB64-BA8F-4F40-9794-F67CDA094300Q82831718-0B717087-580E-4724-A215-38B90491C444Q86875663-8748DFCE-C03A-4EF4-8A31-7E25BAD591E3Q91606422-92F4B333-5A08-475F-85D1-181A4460F3E2Q94668250-8AC4E22A-A69B-44EC-AABD-C663043A6FA9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
S Brozzetti
@ast
S Brozzetti
@en
S Brozzetti
@es
S Brozzetti
@nl
type
label
S Brozzetti
@ast
S Brozzetti
@en
S Brozzetti
@es
S Brozzetti
@nl
prefLabel
S Brozzetti
@ast
S Brozzetti
@en
S Brozzetti
@es
S Brozzetti
@nl
P106
P1153
6602832243
P31
P496
0000-0001-7440-4305